Mantle cell lymphoma trials in Austria

2 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

  Where

  Linz, Salzburg, St. Poelten, Vienna

  Age

  18 years and over

  People

  300 worldwide

  Run by

  BeOne Medicines

  See details and how to joinNCT06742996 · EU 2024-515593-27-00
• Phase 2Taking people
  Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma

  Where

  Vienna

  Age

  18 years to 100 years

  People

  16

  Run by

  Medical University of Vienna

  See details and how to joinNCT05868395 · EU 2024-518704-41-00